CR20170010A - MONOCLONAL ANTIBODIES AGAINST HER2 EPITHOPE AND ITS METHODS OF USE - Google Patents
MONOCLONAL ANTIBODIES AGAINST HER2 EPITHOPE AND ITS METHODS OF USEInfo
- Publication number
- CR20170010A CR20170010A CR20170010A CR20170010A CR20170010A CR 20170010 A CR20170010 A CR 20170010A CR 20170010 A CR20170010 A CR 20170010A CR 20170010 A CR20170010 A CR 20170010A CR 20170010 A CR20170010 A CR 20170010A
- Authority
- CR
- Costa Rica
- Prior art keywords
- monoclonal antibodies
- methods
- epithope
- antibodies against
- against her2
- Prior art date
Links
Abstract
La presente invención proporciona anticuerpos monoclonales completamente humanos que reconocen HER2. La invención también proporciona métodos de uso de tales anticuerpos monoclonales en una variedad de indicadores terapéuticos, diagnósticos y preventivos.The present invention provides fully human monoclonal antibodies that recognize HER2. The invention also provides methods of using such monoclonal antibodies in a variety of therapeutic, diagnostic and preventive indicators.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462013944P | 2014-06-18 | 2014-06-18 | |
US201462034489P | 2014-08-07 | 2014-08-07 | |
US201562147960P | 2015-04-15 | 2015-04-15 | |
US201561149444P | 2015-04-17 | 2015-04-17 | |
PCT/US2015/036431 WO2015195917A1 (en) | 2014-06-18 | 2015-06-18 | Monoclonal antibodies against her2 epitope and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CR20170010A true CR20170010A (en) | 2017-04-20 |
Family
ID=59676865
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR20170010A CR20170010A (en) | 2014-06-18 | 2015-06-18 | MONOCLONAL ANTIBODIES AGAINST HER2 EPITHOPE AND ITS METHODS OF USE |
Country Status (1)
Country | Link |
---|---|
CR (1) | CR20170010A (en) |
-
2015
- 2015-06-18 CR CR20170010A patent/CR20170010A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2016000315A (en) | MONOCLONAL ANTIBODIES AGAINST THE HER2 EPITHOPE AND ITS METHODS OF USE | |
MY191169A (en) | Anti-fcrh5 antibodies | |
PH12016501894A1 (en) | Anti-ox40 antibodies and methods of use | |
PH12016501618A1 (en) | Anti-dll3 antibodies and drug conjugates for use in melanoma | |
CO2017004516A2 (en) | Humanized anti-ox40 antibodies | |
PH12020550781A1 (en) | Anti-jagged1 antibodies and methods of use | |
PH12017500322A1 (en) | Anti-her2 antibodies and immunoconjugates | |
PH12017500877B1 (en) | ANTI-CD79b ANTIBODIES AND METHODS OF USE | |
EA201790569A1 (en) | ANTIBODIES AND IMMUNOCONJUGATES AGAINST CLL-1 | |
MY193661A (en) | Anti-tim3 antibodies and methods of use | |
MY188940A (en) | Anti-pd-l1 antibodies and diagnostic uses thereof | |
MX2015012326A (en) | Anti-crth2 antibodies and their use. | |
MX2016015162A (en) | Anti-gpc3 antibodies and immunoconjugates. | |
NZ761537A (en) | Anti-human ox40l antibodies, uses & methods | |
MX2016004853A (en) | ANTI-Ly6E ANTIBODIES AND METHODS OF USE. | |
BR112017009792A2 (en) | anti-pdgf-b antibodies and methods of use | |
MA40535A (en) | Hsp90-targeted inflammation and infection imaging and therapy | |
CR20170010A (en) | MONOCLONAL ANTIBODIES AGAINST HER2 EPITHOPE AND ITS METHODS OF USE | |
EA201692560A1 (en) | MONOCLONAL ANTIBODIES AGAINST THE HER2 EPITOPE AND METHODS OF THEIR APPLICATION | |
AR105316A1 (en) | ANTIBODIES AGAINST THE TRANSFERRINE RECEIVER (ANTI-CD71), ANTI-CD71 ACTIVABLES ANTIBODIES AND THEIR METHODS OF USE | |
NZ744340A (en) | Anti-jagged1 antibodies and methods of use |